Telemetry Investments’s Revelation Biosciences Warrant REVBW Stock Holding History

Telemetry Investments’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2K	Hold	143,115	–	–	﹤0.01%	131
2022 Q3	$6K	Hold	143,115	–	–	0.01%	152
2022 Q2	$10K	Hold	143,115	–	–	0.01%	156
2022 Q1	$19K	Buy	143,115 +62,319	+77%	+$15.9K	0.03%	145
2021 Q4	$55K	Hold	80,796	–	–	0.07%	154
2021 Q3	$49K	Buy	+80,796	New	+$49K	0.07%	150

Other funds holding REVBW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Telemetry Investments's REVBW Position: Q4 2022 in Review

Telemetry Investments held its Revelation Biosciences Warrant (REVBW) position steady in Q4 2022 at 143,115 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #131.

Telemetry Investments first reported a position in REVBW in Q3 2021 and has held it in 6 quarters since. The position peaked at $55K in Q4 2021. 11 funds tracked by Wall St. Rank hold REVBW as of Q4 2022.

Telemetry Investments held 143,115 shares of Revelation Biosciences Warrant worth $2K as of Q4 2022.
Telemetry Investments left its Revelation Biosciences Warrant share count unchanged in Q4 2022.
Revelation Biosciences Warrant made up ﹤0.01% of Telemetry Investments's portfolio in Q4 2022, its #131 holding.
Telemetry Investments first reported a position in Revelation Biosciences Warrant in Q3 2021 and has held it in 6 quarters since.
Telemetry Investments's Revelation Biosciences Warrant position peaked at $55K in Q4 2021.
11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.